| VOL. 29, NO. 1 | November, 2003 |
|---|
| Michael A. Nader, Ph.D. Department of Physiology & Pharmacology Wake Forest University School of Medicine Medical Center Blvd. Winston-Salem, NC, 27157 tel: (336) 713-7172 email: mnader@wfubmc.edu |
Richard W. Foltin, Ph.D. Department of Psychiatry College of Physicians and Surgeons of Columbia University 1051 Riverside Dr., Unit 120 New York, NY 10032 (212) 543-5717 rwf2@columbia.edu |
| Jonathan B. Kamien, Ph.D. BioPsych Consulting 3450 Vista Haven Road Sherman Oaks, CA 91403 email: jkamien@biopsych.com |
Marilyn E. Carroll, Ph.D. Dept. of Psychiatry University of Minnesot Box 392 UMHC Minneapolis, MN 554544 (612) 626-6289 email: mcarroll@staff.tc.umn.edu |
ISGIDAR e-mail address: ISGIDAR-L@venus.vcu.edu
INDEX
The 2003 annual ISGIDAR Scientific Meeting was held Saturday 14 June at the Sheraton Bal Harbour Beach Resort in Bal Harbour, Florida. This was our 29th annual meeting. As usual, the meeting was held as a satellite session immediately preceding the annual scientific meeting of the College on Problems of Drug Dependence. An outstanding series of scientific papers was presented between 9:00 and 5:00 PM (all ISIGIDAR programs are HERE) and the business meeting was held immediately thereafter.
Minutes of the Business Meeting
| William Stoops | Andrew Morgan |
| Cynthia Conklin | Jennifer Perry |
| Anthony Riley | Erin Larson |
| Mark LeSage | Megan Roth |
| Suzana Justinova | Jason Ross |
| Marcello Solinas | Renee Claytor |
| Sarah Ward | Joshua Lile |
| Brett Ginsberg | William Fantegrossi |
| Suzanne Vosburg |
Respectfully, your Secretary,
Richard W. Foltin, Ph.D.
The 2004 annual ISGIDAR Scientific Meeting will be held at the Caribe Hilton immediately preceding the annual scientific meeting of the College on Problems of Drug Dependence. ISGIDAR registration will begin at 8:30AM on Saturday, June 12, 2003. The registration fee is $50. Paper presentations will be scheduled between 9:00AM and 5:00PM and the business meeting will be held from 5:00 to 5:30 PM.
If you wish to advance register ($50 does not include lunch), please send a check, payable to ISGIDAR, to Dr. Marilyn Carroll, Psychiatry Department, Box 392 UMHC, University of Minnesota, Minneapolis, MN 55455. Receipts for meal costs and registration will be provided at the meeting.
As always, we need to plan ahead a little for lunch at the meeting. We can arrange a reasonable buffet style lunch within our normal limits (e.g., $15), but need to get a head count. If you intend to eat at the meeting please e-mail the President.
Nominations for new members should be e-mailed to the President of ISGIDAR and will be collated for a vote by ballot preceding the next annual meeting.
Paper presentations by members are accepted (pending suitability) on a first come-first serve basis. Regrettably, we had to turn back papers by members last year. If you want to present a paper, please e-mail a title and the names of the authors to the President to hold your slot. Likewise additional ideas for Invited Speakers, Symposia, etc. are always appreciated.
POST-DOCTORAL POSITION IN
HUMAN BEHAVIORAL PHARMACOLOGY OF NICOTINE
A post-doctoral position in the behavioral pharmacology of nicotine in humans may be available in the laboratory of Dr. Kenneth A. Perkins at the University of Pittsburgh. Ongoing NIDA-supported projects include those that focus on: 1) environmental modulation of nicotine responses and tobacco self-administration, 2) individual differences associated with sensitivity to nicotine, including gender, genetic, and personality factors. Applicants also interested in clinical research may become involved in smoking cessation studies.
Interested candidates should send a C.V. and letter of interest to Dr. Perkins at the following address:
Kenneth A. Perkins, Ph.D.
Department of Psychiatry
University of Pittsburgh Medical Center
3811 O'Hara Street
Pittsburgh, PA 15213
voice: (412) 246-5395
fax: (412) 246-5390
email: perkinska@upmc.edu
website: http://myprofile.cos.com/perkinsk31
POST-DOCTORAL RESEARCH ASSOCIATE: DRUG ABUSE RESEARCH
Applications are invited for a Post-Doctoral Research Associate position in the Department of Psychiatry and Human Behavior at the University of Mississippi Medical Center. Candidates should have a Ph.D. in Pharmacology, Psychology, or Neuroscience and expertise in drug
abuse research using non-human subjects. The research program emphasizes drug self-administration studies with non-human primates. Experience with non-human primates is desirable but not essential. Applicants should send curriculum vitae, a statement of research
interests and goals, and names of three references to:
William L. Woolverton, Ph.D.
Department of Psychiatry and Human Behavior, The University of
Mississippi Medical Center, 2500 North State Street
Jackson, MS 39216.
NIDA/NIAAA Research Training Programs in Substance Abuse Intervention Research and Alcohol Treatment Research at the Center for Alcohol and Addiction Studies, Brown University
Biomedical, behavioral, social, and health care scientists wishing to pursue a career in alcohol or other substance abuse research are invited to apply for positions in the Brown University training programs in Substance Abuse Intervention Outcome Research or in Alcohol Treatment and Early Intervention Research. The Brown programs, funded by NIDA and NIAAA, prepare professionals to conduct high quality research in intervention of alcohol or other drug abuse. Weekly seminars and colloquia emphasize conceptualization and conduct of research. The training program focuses on the development and implementation of on-site research under the supervision of trainee-selected faculty mentors. Trainees have opportunities to present their work and interact with the Brown faculty through the program of the Center for Alcohol and Addiction Studies. Through collaboration, Brandeis University faculty are also available as mentors for those fellows specializing in health services delivery research. Key research programs ongoing at the Center include rodent models of systems mediating alcohol and other drug reinforcement, consumption and sensitization; human behavioral pharmacology lab studies of smoking, alcohol and other drug use; behavioral and pharmacological treatment studies; prenatal effects of drugs and alcohol; and genetic underpinnings of drug and alcohol use in humans. The Center currently has over 30 research grants focused on substance use, representing nearly 5 million in direct costs per year. The Center is part of the Public Health Program in the Brown Medical School. Brown Medical School is an Equal Opportunity Affirmative Action employer and actively encourages applications from women, minorities, and protected persons.
Application review will begin on January 15, 2004 and will continue until the positions are filled or the search is closed. For further details and application materials go to: www.caas.brown.
or phone: (401) 444-1833, or email: Postdoc_training@brown.edu
SUBSTANCE ABUSE RESEARCH AT JOHNS HOPKINS
Postdoctoral research fellowships in stimulating, productive program with excellent resources. Prepare as independent investigator.
HUMAN LABORATORY -- behavioral & clinical pharmacology of abused drugs (abuse liability, self-administration, cognitive function, neuroimaging); anti-drug-abuse medications development. Opioids, cocaine, anxiolytics, alcohol, caffeine, nicotine.
CLINICAL TRIALS testing medications, verbal & behavioral therapies (esp. incentive/motivation-based), and combinations; psychiatric comorbidity research; addiction & pregnancy/women. Opioid, cocaine, tobacco, mixed/other dependencies.
Start Date: Flexible, some now.
Eligibility: citizen, permanent resident. A broad range of backgrounds are appropriate from clinical/counseling to experimental/neuroscience.
NIH stipend levels: $31-49K+.
Contact Sharon Walsh, George Bigelow, Roland Griffiths, or Maxine Stitzer; BPRU, Behavioral Biology Research Center;. 5510 Nathan Shock Drive; Johns Hopkins Bayview Campus; Baltimore, Maryland 21224-6823. (410) 550-1060; swalsh@jhmi.edu. Cf http://bpru.med.jhu.edu